Jefferies analysts identified their preferred mid-cap biotechnology stocks ahead of third-quarter earnings, with Oncorus (ONC) emerging as their top commercial pick, followed by Revolution Medicines ...

Boosted by its exclusive agreement with Regeneron, Kiniksa Pharmaceuticals stands among the top biotech stocks to watch.

Three biotech stocks are making their mark, hovering around the top of the IBD 50 list, and even held all three top slots at one time over the past week. Eight biotech stocks made the list but Travere ...

Alaunos Therapeutics (NASDAQ: TCRT) jumps over 146% after completing its Velaris Therapeutics acquisition and a concurrent ...

Biotech companies are seeing significant pre-market activity this Monday. Mobile- health Network Solutions led the gainers ...

Affinity Technologies (Nasdaq: BIAF) soars after the Japan Patent Office issues a Notice of Allowance for its CyPath Lung ...

Global bond markets have recently steadied after a sharp sell off that pushed borrowing costs to their highest levels since 2002, and that pause is giving Australian biotech stocks fresh attention ...

Biotechnology stocks represent a great opportunity for investors who are fortunate enough to get into the right names at the right time. The biotech stock sector has always been a stellar performer in ...

All that has changed, and if you want to invest in growth away from AI, biotech might be where you want to be. Below, I will attempt to lay out the various macro and policy disruptions that had a ...